Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianmin Zuo

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Pathogens (Basel, Switzerland)|November 4, 2015
Identification of Epstein-Barr Virus Replication Proteins in Burkitt's Lymphoma CellsChris Traylen, Sharada Ramasubramanyan, Jianmin Zuo, et al.
Blood|January 9, 2013
Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205Carol S Leung, Michael A Maurer, Sonja Meixlsperger, et al.
Plos Pathogens|December 29, 2025
Valaciclovir therapy for secondary suppression of immune response to herpesviruses: An exploratory studyKirsty McGee, Alex Dowell, Sarah Lauder, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasionMartin Rowe, Britt Glaunsinger, Daphne van Leeuwen, et al.
Plos Pathogens|January 3, 2009
The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradationJianmin Zuo, Andrew Currin, Bryan D Griffin, et al.
Blood|January 12, 2012
T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cellsShereen Sabbah, Ya Jankey Jagne, Jianmin Zuo, et al.
Blood Advances|January 4, 2018
The number of CD56<sup>dim</sup> NK cells in the graft has a major impact on risk of disease relapse following allo-HSCTLuke Maggs, Francesca Kinsella, Y L Tracey Chan, et al.
Oncoimmunology|December 10, 2020
NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotypeFrancesca Marcon, Jianmin Zuo, Hayden Pearce, et al.
Plos Pathogens|March 4, 2021
PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicityHelen M Parry, Alexander C Dowell, Jianmin Zuo, et al.
Oncotarget|September 23, 2016
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphomaHelen M Parry, Tom Stevens, Ceri Oldreive, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Pathogens (Basel, Switzerland)|November 4, 2015
Identification of Epstein-Barr Virus Replication Proteins in Burkitt's Lymphoma CellsChris Traylen, Sharada Ramasubramanyan, Jianmin Zuo, et al.
Blood|January 9, 2013
Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205Carol S Leung, Michael A Maurer, Sonja Meixlsperger, et al.
Plos Pathogens|December 29, 2025
Valaciclovir therapy for secondary suppression of immune response to herpesviruses: An exploratory studyKirsty McGee, Alex Dowell, Sarah Lauder, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Host shutoff during productive Epstein-Barr virus infection is mediated by BGLF5 and may contribute to immune evasionMartin Rowe, Britt Glaunsinger, Daphne van Leeuwen, et al.
Plos Pathogens|January 3, 2009
The Epstein-Barr virus G-protein-coupled receptor contributes to immune evasion by targeting MHC class I molecules for degradationJianmin Zuo, Andrew Currin, Bryan D Griffin, et al.
Blood|January 12, 2012
T-cell immunity to Kaposi sarcoma-associated herpesvirus: recognition of primary effusion lymphoma by LANA-specific CD4+ T cellsShereen Sabbah, Ya Jankey Jagne, Jianmin Zuo, et al.
Blood Advances|January 4, 2018
The number of CD56<sup>dim</sup> NK cells in the graft has a major impact on risk of disease relapse following allo-HSCTLuke Maggs, Francesca Kinsella, Y L Tracey Chan, et al.
Oncoimmunology|December 10, 2020
NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotypeFrancesca Marcon, Jianmin Zuo, Hayden Pearce, et al.
Plos Pathogens|March 4, 2021
PD-1 is imprinted on cytomegalovirus-specific CD4+ T cells and attenuates Th1 cytokine production whilst maintaining cytotoxicityHelen M Parry, Alexander C Dowell, Jianmin Zuo, et al.
Oncotarget|September 23, 2016
NK cell function is markedly impaired in patients with chronic lymphocytic leukaemia but is preserved in patients with small lymphocytic lymphomaHelen M Parry, Tom Stevens, Ceri Oldreive, et al.
Pageof 8